Literature DB >> 20238205

Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Gianfrancesco Goracci1, Monica Ferrini, Vincenza Nardicchi.   

Abstract

Several "low molecular weight" or "secretory" phospholipases A(2) isoforms may be expressed in mammalian neural cells. Indeed, mRNAs for GIB, GIIA, GIIE, GIII, GV, GX, and GXII were detected in brain tissues despite different levels. However, only the presence of GIB, GIIA, and GV proteins has been clearly demonstrated in neural cells or in the nervous tissue. Although the roles of GIB and GV in the nervous tissue are still elusive, there is evidence to support the involvement of GIIA in physiological and pathological events, including neurotransmission, long-term potentiation, and neuritogenesis. The neurotoxic effects of an increase in GIIA may be envisaged under pathological conditions associated with the activation of astrocytes during inflammation or through activation of neurons and enzymes due to the stimulation of the NMDA glutamate receptor. In the past, elevation of GIIA expression in many acute and chronic neurological diseases is well known. Although each neurodegenerative disease has a separate etiology, many share similar neurochemical common processes, such as excitotoxicity, oxidative stress, and mitochondrial dysfunction, phenomena where GIIA play an important role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238205     DOI: 10.1007/s12035-010-8108-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  175 in total

1.  Cloning and recombinant expression of a novel mouse-secreted phospholipase A2.

Authors:  E Valentin; R S Koduri; J C Scimeca; G Carle; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

2.  Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Brain Res       Date:  2007-01-03       Impact factor: 3.252

3.  Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

Authors:  D T Stephenson; C A Lemere; D J Selkoe; J A Clemens
Journal:  Neurobiol Dis       Date:  1996-02       Impact factor: 5.996

4.  Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain.

Authors:  Teng-Nan Lin; Qun Wang; Agnes Simonyi; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Jan Xu; Albert Y Sun; Chung Y Hsu; Grace Y Sun
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

5.  Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans.

Authors:  Eric Boilard; Sylvain G Bourgoin; Chantale Bernatchez; Patrice E Poubelle; Marc E Surette
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

6.  Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human.

Authors:  J A Tischfield; Y R Xia; D M Shih; I Klisak; J Chen; S J Engle; A N Siakotos; M V Winstead; J J Seilhamer; V Allamand; G Gyapay; A J Lusis
Journal:  Genomics       Date:  1996-03-15       Impact factor: 5.736

7.  Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease.

Authors:  Athena Kalyvas; Samuel David
Journal:  Neuron       Date:  2004-02-05       Impact factor: 17.173

Review 8.  The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

Authors:  Lee J Martin
Journal:  Biochim Biophys Acta       Date:  2009-08-03

9.  Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation.

Authors:  Florence Pinto; Talma Brenner; Phyllis Dan; Miron Krimsky; Saul Yedgar
Journal:  Glia       Date:  2003-12       Impact factor: 7.452

10.  Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

Authors:  Rob C Oslund; Nathan Cermak; Michael H Gelb
Journal:  J Med Chem       Date:  2008-07-08       Impact factor: 7.446

View more
  7 in total

1.  Effect of NGF on the subcellular localization of group IIA secretory phospholipase A(2) (GIIA) in PC12 cells: role in neuritogenesis.

Authors:  M Ferrini; V Nardicchi; R Mannucci; C Arcuri; I Nicoletti; R Donato; G Goracci
Journal:  Neurochem Res       Date:  2010-12-02       Impact factor: 3.996

2.  Expression and localization of sPLA2-III in the rat CNS.

Authors:  Hui Yang; Nikhat J Siddiqi; A S Alhomida; Wei-Yi Ong
Journal:  Neurochem Res       Date:  2013-01-31       Impact factor: 3.996

Review 3.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

4.  NGF induces the expression of group IIA secretory phospholipase A2 in PC12 cells: the newly synthesized enzyme is addressed to growing neurites.

Authors:  Vincenza Nardicchi; Monica Ferrini; Francesca Pilolli; Emanuela Biagioni Angeli; Emanuele Persichetti; Tommaso Beccari; Roberta Mannucci; Cataldo Arcuri; Rosario Donato; Robert V Dorman; Gianfrancesco Goracci
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

5.  Effect of repetitive daily ethanol intoxication on adult rat brain: significant changes in phospholipase A2 enzyme levels in association with increased PARP-1 indicate neuroinflammatory pathway activation.

Authors:  Nuzhath F Tajuddin; Magdalena M Przybycien-Szymanska; Toni R Pak; Edward J Neafsey; Michael A Collins
Journal:  Alcohol       Date:  2012-10-25       Impact factor: 2.405

6.  The neurotoxic secreted phospholipase A2 from the Vipera a. ammodytes venom targets cytochrome c oxidase in neuronal mitochondria.

Authors:  Jernej Šribar; Lidija Kovačič; Jernej Oberčkal; Adrijan Ivanušec; Toni Petan; Jay W Fox; Igor Križaj
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

7.  Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.

Authors:  Alyson A Kelvin; Norbert Degousee; David Banner; Eva Stefanski; Alberto J Leόn; Denis Angoulvant; Stéphane G Paquette; Stephen S H Huang; Ali Danesh; Clinton S Robbins; Hossein Noyan; Mansoor Husain; Gerard Lambeau; Michael Gelb; David J Kelvin; Barry B Rubin
Journal:  Virology       Date:  2014-02-25       Impact factor: 3.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.